Genpharmasec Ltd Fixes AGM Date, Approves Director's Report
Genpharmasec Ltd announced outcomes of its Board of Directors meeting held on September 2, 2026. The board has fixed Tuesday, September 29, 2026, as the date for the 34th Annual General Meeting (AGM), to be conducted via Video Conferencing. Key decisions include approving the Director's Report and Annual Report for FY 2025-26, setting September 22, 2026, as the cut-off date for voting rights, and scheduling e-voting from September 26 to September 28, 2026. The company also approved the closure of Share Transfer Books from September 23 to September 29, 2026, for the AGM. Additionally, M/S. Jaymin Modi & Co. was appointed as the scrutinizer for the AGM, and Mr. Sohan Chaturvedi's re-appointment as Whole Time Director was approved, subject to shareholder consent.
Key Highlights
- AGM scheduled for September 29, 2026, via VC/OAVM.
- Director's Report and Annual Report for FY 2025-26 approved.
- E-voting period set from September 26-28, 2026.
- Share transfer books to close September 23-29, 2026.
- Re-appointment of Mr. Sohan Chaturvedi as Whole Time Director approved.
Price Impact
More from GENPHARMA